{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:35:45Z","timestamp":1792794945729,"version":"4.5.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013297","name":"Eurostars","doi-asserted-by":"publisher","award":["E!114787 ENVISAGE"],"award-info":[{"award-number":["E!114787 ENVISAGE"]}],"id":[{"id":"10.13039\/100013297","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Development of\n                      <jats:italic>de novo<\/jats:italic>\n                      donor-specific antibodies (dnDSA) remains a key risk factor for antibody-mediated rejection and graft loss in kidney transplantation. The PIRCHE-T2 model estimates immunogenicity by predicting donor-derived HLA peptides presented via the recipient\u2019s HLA class II molecules. A recent update to the model integrates a new neural network-based peptide-binding predictor \u201cFrost\u201d, which requires further testing of clinical performance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We compared the predictive performance of the previous and updated PIRCHE-T2 models in two independent kidney transplant cohorts from Zurich (n = 1194) and Basel (n = 387). PIRCHE-T2 scores were assessed at total and locus-specific levels and analyzed in relation to dnDSA incidence using ROC curves, Kaplan-Meier, and Cox regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The updated PIRCHE-T2 model generated lower and more condensed scores but improved dnDSA risk stratification across both cohorts. Higher scores remained associated with increased dnDSA risk. Notable improvements were observed for HLA-C scores. HLA-DQ also showed enhanced performance in one-mismatch subgroups and Cox models, while HLA-A improvements were primarily seen in the Basel cohort. Results for other loci remained similar between models, although HLA-DRB1 showed cohort-specific variation, highlighting the need for context-specific threshold refinement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrate that the updated PIRCHE-T2 model refines immunological risk stratification in kidney transplantation, offering improved performance for certain loci and patient subgroups. Its application may support more precise donor selection and individualized immunological assessment. Given observed cohort-specific differences, future work should focus on optimizing thresholds and validating the model across diverse populations to ensure broader clinical applicability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1809989","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:14:05Z","timestamp":1776658445000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of dnDSA risk stratification using the updated PIRCHE-T2 model in two kidney transplant cohorts"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuan","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Immunology, University Hospital Zurich (USZ)","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Niemann","sequence":"additional","affiliation":[{"name":"Research and Development, PIRCHE AG","place":["Berlin, Germany"]},{"name":"Department of Nephrology and Medical Intensive Care, Charit\u00e9 Universit\u00e4tsmedizin Berlin","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict M.","family":"Matern","sequence":"additional","affiliation":[{"name":"Research and Development, PIRCHE AG","place":["Berlin, Germany"]},{"name":"Center for Translational Immunology, University Medical Center Utrecht","place":["Utrecht, Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Frischknecht","sequence":"additional","affiliation":[{"name":"Department of Immunology, University Hospital Zurich (USZ)","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mallone","sequence":"additional","affiliation":[{"name":"Department of Immunology, University Hospital Zurich (USZ)","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"R\u00f6ssler","sequence":"additional","affiliation":[{"name":"Department of Surgery and Transplantation, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schachtner","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Hospital Zurich","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schaub","sequence":"additional","affiliation":[{"name":"Clinic for Transplantation Immunology and Nephrology, University Hospital Basel","place":["Basel, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Immunology, University Hospital Zurich (USZ)","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1802677","article-title":"Antibody-mediated rejection of solid-organ allografts","volume":"379","author":"Loupy","year":"2018","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13347","article-title":"Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody","volume":"15","author":"Wiebe","year":"2015","journal-title":"Am J Transplant"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1005790","article-title":"The impact of pre-transplant donor specific antibodies on the outcome of kidney transplantation - Data from the Swiss transplant cohort study","volume":"13","author":"Frischknecht","year":"2022","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199911270-00027","article-title":"Impact of acute rejection therapy on infections and Malignancies in renal transplant recipients","volume":"68","author":"Jamil","year":"1999","journal-title":"Transplantation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/TP.0000000000000869","article-title":"The influence of immunosuppressive agents on the risk of de novo donor-specific HLA antibody production in solid organ transplant recipients","volume":"100","author":"O\u2019Leary","year":"2016","journal-title":"Transplantation"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman","year":"2007","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldv013","article-title":"Kidney transplantation in highly sensitized patients","volume":"114","author":"Jordan","year":"2015","journal-title":"Br Med Bull"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14393","article-title":"Donor\u2013recipient matching based on predicted indirectly recognizable HLA epitopes independently predicts the incidence of de novo donor-specific HLA antibodies following renal transplantation","volume":"17","author":"Lachmann","year":"2017","journal-title":"Am J Transplant"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00321","article-title":"PIRCHE-II is related to graft failure after kidney transplantation","volume":"9","author":"Geneugelijk","year":"2018","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.949933","article-title":"PIRCHE-II scores prove useful as a predictive biomarker among kidney transplant recipients with rejection: an analysis of indication and follow-up biopsies","volume":"13","author":"Spitznagel","year":"2022","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1508586","article-title":"De novo donor-specific HLA antibody development after kidney transplantation is impacted by PIRCHE II score and recipient age","volume":"16","author":"Tian","year":"2025","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14052","article-title":"Association between PIRCHE-II scores and de novo allosensitization after reduction of immunosuppression during SARS-CoV-2 infection in kidney transplant recipients","volume":"25","author":"Castrezana-Lopez","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.788818","article-title":"High PIRCHE scores may allow risk stratification of borderline rejection in kidney transplant recipients","volume":"13","author":"Lezoeva","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2024.13720","article-title":"Assessing the predictive power of PIRCHE-II scores for the development of de novo donor-specific antibodies after simultaneous pancreas-kidney transplantation","volume":"37","author":"Raineri","year":"2024","journal-title":"Transpl Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/tan.15748","article-title":"Combined molecular mismatch approaches to predict immunological events within the first year after renal transplantation","volume":"104","author":"J\u00e4ger","year":"2024","journal-title":"Hla"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1530065","DOI":"10.1007\/s10623-023-01277-7","article-title":"Evaluation of de novo donor specific antibodies after kidney transplantation in the era of donor-derived cell-free DNA","volume":"15","author":"Tian","year":"2024","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/iji.12359","article-title":"Matching donor and recipient based on predicted indirectly recognizable human leucocyte antigen epitopes","volume":"45","author":"Geneugelijk","year":"2018","journal-title":"Int J Immunogenet"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1548934","article-title":"Advancing risk stratification in kidney transplantation: integrating HLA-derived T-cell epitope and B-cell epitope matching algorithms for enhanced predictive accuracy of HLA compatibility","volume":"16","author":"Niemann","year":"2025","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1508796","article-title":"De novo donor-specific anti-HLA antibody risk stratification in kidney transplantation using a combination of B cell and T cell molecular mismatch assessment","volume":"16","author":"Chou-Wu","year":"2025","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"Imeta"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu393","article-title":"circlize implements and enhances circular visualization in R","volume":"30","author":"Gu","year":"2014","journal-title":"Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-019-01140-x","article-title":"PIRCHE-II: an algorithm to predict indirectly recognizable HLA epitopes in solid organ transplantation","volume":"72","author":"Geneugelijk","year":"2020","journal-title":"Immunogenetics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1442018","article-title":"Improving long-term kidney allograft survival by rethinking HLA compatibility: from molecular matching to non-HLA genes","volume":"15","author":"Mattoo","year":"2024","journal-title":"Front Genet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2024.110813","article-title":"High-resolution HLA genotyping improves PIRCHE-II assessment of molecular mismatching in kidney transplantation","volume":"85","author":"Crane","year":"2024","journal-title":"Hum Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1809989\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:14:07Z","timestamp":1776658447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1809989\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2026.1809989"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1809989","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1809989"}}